The potential action of galactose as a “chemical chaperone”: Increase of beta galactosidase activity in fibroblasts from an adult GM1-gangliosidosis patient-Reference-Cited by-同舟云学术

The potential action of galactose as a “chemical chaperone”: Increase of beta galactosidase activity in fibroblasts from an adult GM1-gangliosidosis patient

Published:2009-03 Issue:2 Volume:13 Page:160-164
ISSN:1090-3798
Container-title:European Journal of Paediatric Neurology
language:en
Short-container-title:European Journal of Paediatric Neurology

Author:

Caciotti Anna,Donati Maria Alice,d'Azzo Alessandra,Salvioli Rosa,Guerrini Renzo,Zammarchi Enrico,Morrone Amelia

Publisher

Elsevier BV

Subject

Clinical Neurology,General Medicine,Pediatrics, Perinatology, and Child Health

Reference24 articles.

1. ß-galactosidase deficiency (ß-galactosidosis) GM1-gangliosidosis and Morquio B disease;Suzuki,2001

2. Insights into the diagnosis and treatment of lysosomal storage diseases;Wenger;Arch Neurol,2003

3. N-Butyldeoxygalactonojirimycin inhibits glycolipid biosynthesis but does not affect N-linked oligosaccharide processing;Platt;J Biol Chem,1994

4. Beta-galactosidase deficiency: an approach to chaperone therapy;Suzuki;J Inherit Metab Dis,2006

5. Inhibition of substrate synthesis as a strategy for glycolipid lysosomal storage disease therapy;Platt;J Inherit Metab Dis,2001

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ganglioside GM1 and the Central Nervous System;International Journal of Molecular Sciences;2023-05-31

2. GM1 Gangliosidosis: Mechanisms and Management;The Application of Clinical Genetics;2021-04

3. Lysosomal Storage Disorders;Emery and Rimoin's Principles and Practice of Medical Genetics and Genomics;2021

4. Advances in the Development of Pharmacological Chaperones for the Mucopolysaccharidoses;International Journal of Molecular Sciences;2019-12-29

5. Morquio‐B disease: Clinical and genetic characteristics of a distinct GLB1 ‐related dysostosis multiplex;JIMD Reports;2019-11-28